Hedge Fund and Insider Trading News: Carl Icahn, Crispin Odey, ValueAct Capital, La Jolla Pharmaceutical (LJPC), New Mountain Finance Corp. (NMFC), and More

Insider Buying: La Jolla Pharmaceutical (LJPC) Director Buys 1,300,000 Shares of Stock (MareaInformativa.com)
La Jolla Pharmaceutical (NASDAQ:LJPC) Director Kevin C. Tang purchased 1,300,000 shares of the firm’s stock in a transaction on Wednesday, January 9th. The shares were acquired at an average cost of $5.37 per share, for a total transaction of $6,981,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: New Mountain Finance Corp. (NMFC) Director Purchases 181,805 Shares of Stock (PressOracle.com)
New Mountain Finance Corp. (NYSE:NMFC) Director Steven B. Klinsky purchased 181,805 shares of New Mountain Finance stock in a transaction that occurred on Monday, December 17th. The stock was acquired at an average cost of $12.52 per share, with a total value of $2,276,198.60. Following the acquisition, the director now directly owns 56,009 shares in the company, valued at approximately $701,232.68. The acquisition was disclosed in a document filed with the SEC.

Insider Selling: Portola Pharmaceuticals Inc (PTLA) Director Sells 64,218 Shares of Stock (BaseballDailyDigest.com)
Portola Pharmaceuticals Inc (NASDAQ:PTLA) Director Charles J. Homcy sold 64,218 shares of the company’s stock in a transaction on Monday, December 17th. The stock was sold at an average price of $18.61, for a total transaction of $1,195,096.98. The sale was disclosed in a filing with the Securities & Exchange Commission.

Insider Selling: Genomic Health, Inc. (GHDX) CEO Sells 25,000 Shares of Stock (ModernReaders.com)
Genomic Health, Inc. (NASDAQ:GHDX) CEO Kimberly J. Popovits sold 25,000 shares of Genomic Health stock in a transaction that occurred on Monday, December 17th. The stock was sold at an average price of $66.89, for a total value of $1,672,250.00. The sale was disclosed in a document filed with the SEC.

Insider Buying: Meet Group Inc (MEET) Major Shareholder Acquires $284,477.34 in Stock (MareaInformativa.com)
Meet Group Inc (NASDAQ:MEET) major shareholder Luxor Capital Group, Lp bought 58,898 shares of the business’s stock in a transaction that occurred on Friday, January 4th. The shares were acquired at an average price of $4.83 per share, for a total transaction of $284,477.34. The purchase was disclosed in a legal filing with the SEC.